---
schema_version: "secwatch.filing_event.v1"
accession: "0000719135-23-000049"
form_type: "8-K"
ticker: "APYX"
cik: "0000719135"
company_name: "Apyx Medical Corp"
filed_at: "2023-08-16T23:59:59+00:00"
generated_at: "2026-06-11T08:56:37.780348+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Apyx Medical annual meeting elects 8 directors, ratifies auditor, approves 2023 incentive plan

## Summary
- All 8 director nominees elected, including Andrew Makrides (18.7M for, 224K against) and Charles Goodwin (19.0M for, 21K against).
- Ratification of RSM US LLP as auditor: 24,542,917 for, 26,534 against, 53,343 abstentions.
- Approval of 2023 Share Incentive Plan: 15,970,459 for, 1,405,162 against, 1,613,512 abstentions.
- Meeting held August 10, 2023; all proposals passed as recommended by the Board.

## SEC filing metadata
- accession: 0000719135-23-000049
- form_type: 8-K
- ticker: APYX
- cik: 0000719135
- company_name: Apyx Medical Corp
- filed_at: 2023-08-16T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/719135/000071913523000049/0000719135-23-000049-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/719135/000071913523000049/apyx-20230810.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000719135-23-000049
- JSON: https://secwatch.observer/filing/0000719135-23-000049.json
- Plain text: https://secwatch.observer/filing/0000719135-23-000049.txt

## Key facts
- Shareholder Votes
  Apyx Medical Corp shareholders approved Ratification of RSM US LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-08-10 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-08-10
  source text: Proposal 2: The Company’s stockholders ratified the appointment of RSM US LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023 by the following vote: Number of Votes Cast in Favor Number of Votes Cast Against Number of Votes Abstained 24,542,917 26,534 53,343
  evidence_url: https://www.sec.gov/Archives/edgar/data/719135/000071913523000049/0000719135-23-000049-index.htm
- Shareholder Votes
  Apyx Medical Corp shareholders approved Election of eight directors at the 2023-08-10 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-08-10
  source text: On August 10, 2023, the following proposals were submitted to the stockholders of Apyx Medical Corporation (the “Company”) at its annual meeting of stockholders: (1) the election of eight (8) directors; (2) the ratification of RSM US LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023; and (3) the approval of the Company’s 2023 Share Incentive Plan.
  evidence_url: https://www.sec.gov/Archives/edgar/data/719135/000071913523000049/0000719135-23-000049-index.htm
- Shareholder Votes
  Apyx Medical Corp shareholders approved Approval of the 2023 Share Incentive Plan at the 2023-08-10 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-08-10
  source text: Proposal 3: The Company’s stockholders approved the Company’s 2023 Share Incentive Plan by the following vote: Number of Votes Cast in Favor Number of Votes Cast Against Number of Votes Abstained 15,970,459 1,405,162 1,613,512
  evidence_url: https://www.sec.gov/Archives/edgar/data/719135/000071913523000049/0000719135-23-000049-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.